Rating
References
Examine impressive results for simple, uncomplicated clot prevention
See study designs and results for the rivaroxaban phase III studies
View the direct inhibition of Factor Xa, an active area of research
Thromboembolic disorders pose life threatening risks to millions of patients
Connect with a world of events devoted to thromboembolic research
Learn more about ‘Xarelto’ and Thrombosis by watching videos and using interactive tools
Xarelto Countdown
Desirable Characteristics of an Anticoagulant
History of Warfarin
Pooled Analysis of RECORD1, 2, and 3
Results of the Landmark RECORD Programme
Now Playing:
Why a blood clot is serious
Related Videos:
Mode of Action of ‘Xarelto’
Challenging the Burden of Mortality in ACS
Potential Health Economics Benefits of 'Xarelto'
Xarelto® (rivaroxaban) is Highly Effective in Treating Acute DVT and Preventing Recurrent VTE
Highly Effective Protection with Xarelto®
Reassuring Safety Profile of Xarelto
Xarelto® (rivaroxaban): The First Single-Drug Solution for VTE Treatment (Summary)